Pulmonary Hypertension

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

Does Pre-Existing PH Affect Outcomes in Transcatheter Mitral Valve Repair?    Pulmonology Advisor In patients undergoing transcatheter mitral valve repair (TMVR) with the Mitraclip device, pre-existing pulmonary hypertension (PH) is not associated with ...

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival    Medscape Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with ...

Bellerophon Therapeutics (BLPH) Sees Unusually-High Trading Volume    Fairfield Current Bellerophon Therapeutics Inc (NASDAQ:BLPH) shares saw strong trading volume on Monday . 1671001 shares changed hands during mid-day trading, ...

Top 10 Pulmonary Hypertension Stories of 2018    Pulmonary Hypertension News The top 10 pulmonary hypertension (PH) stories of 2018 dealt primarily with new strategies to diagnose and treat the disease.

Top 10 Pulmonary Hypertension Stories of 2018    Pulmonary Hypertension News The top 10 pulmonary hypertension (PH) stories of 2018 dealt primarily with new strategies to diagnose and treat the disease.

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

Bellerophon Therapeutics (BLPH) Upgraded to “Buy” by Zacks Investment Research    Fairfield Current Bellerophon Therapeutics (NASDAQ:BLPH) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on ...

ValuEngine Lowers Bellerophon Therapeutics (NASDAQ:BLPH) to Hold    Fairfield Current Bellerophon Therapeutics (NASDAQ:BLPH) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report ...

Bellerophon Therapeutics (BLPH) Upgraded to “Buy” by Zacks Investment Research    Fairfield Current Bellerophon Therapeutics (NASDAQ:BLPH) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on ...

ValuEngine Lowers Bellerophon Therapeutics (NASDAQ:BLPH) to Hold    Fairfield Current Bellerophon Therapeutics (NASDAQ:BLPH) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report ...

Marshall & Sullivan Has Decreased Its Expeditors Intl Wash (EXPD) Holding; Bellerophon Therapeutics (BLPH) Shorts Decreased By 59.35%    The FinExaminer Marshall & Sullivan Inc decreased Expeditors Intl Wash Inc (EXPD) stake by 58.11% reported in 2018Q3 SEC filing. Marshall & Sullivan Inc sold 4162 shares as ...

Bellerophon Therapeutics (NASDAQ:BLPH) Lowered to Hold at ValuEngine    XNewsPress Bellerophon Therapeutics (NASDAQ:BLPH) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued to ...

Bellerophon Therapeutics (NASDAQ:BLPH) Lowered to “Hold” at ValuEngine    PressOracle Bellerophon Therapeutics (NASDAQ:BLPH) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on ...

Bellerophon Therapeutics (NASDAQ:BLPH) Lowered to “Hold” at ValuEngine    PressOracle Bellerophon Therapeutics (NASDAQ:BLPH) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on ...

Top 10 Pulmonary Hypertension Stories of 2018    Pulmonary Hypertension News The top 10 pulmonary hypertension (PH) stories of 2018 dealt primarily with new strategies to diagnose and treat the disease.

ValuEngine Lowers Bellerophon Therapeutics (NASDAQ:BLPH) to Hold    Fairfield Current Bellerophon Therapeutics (NASDAQ:BLPH) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report ...

Bellerophon Therapeutics (BLPH) Upgraded to “Buy” by Zacks Investment Research    Fairfield Current Bellerophon Therapeutics (NASDAQ:BLPH) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on ...